explore -WSS

explore

author：knowledge 2025-09-27 16:49:23 - browse：57

STAT

There’s nothing better than a beautiful spring day after a long, cold winter. But there’s nothing worse than having that day ruined by the sneezing, sniffling, and itching that come with seasonal allergies.

Scientists don’t actually completely understand why we get seasonal allergies. The best estimation is that they’re an immune response to toxins in the natural environment that pollen also happens to trigger. That immune response begins with the production of IgE antibodies to combat the pollen. The antibodies link up with mast cells, and together they’re a ticking time bomb. When more allergens come along, they activate all those horrible symptoms.

In the new episode of “Boddities,” we dive into how this response happens, and what you can do about it to ease the symptoms and enjoy the season.

Watch other “Boddities” episodes:

Related: Watch: Episode 6: What happens to the brain when we get scared?

Related: Watch: Episode 4: Why do our ears pop?

Related: Episode 5: Why do bright lights make us see spots?

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Burning questions for the 2024 JPM Healthcare Conference

hotspot

focus

WSS

Readout Newsletter: XBI biotech index, Akero Therapeutics

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Goldman Sachs launches $650M fund for life science investments

Federal weight loss drug coverage is 30 years out of date

A single drug, study failures leave Anavex with nothing but cash

FDA has safety concerns on CRISPR

Wikipedia

explore

Related: Watch: Episode 6: What happens to the brain when we get scared?

Related: Watch: Episode 4: Why do our ears pop?

Related: Episode 5: Why do bright lights make us see spots?

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

FDA has safety concerns on CRISPR

Hepatitis C has a cure — but many Americans still lack access to it

Antibiotic resistance and the global rise in human conflict

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Goldman Sachs launches $650M fund for life science investments

As demand for Covid shots wanes, Moderna seeks its next success

Testing for cancer recurrence creates a new limbo for patients

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

U.K. sequencing study surfaces new findings about tumor DNA

hotspot

Testing for cancer recurrence creates a new limbo for patients

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Meta's Zuckerberg and Chan on track to put $50 billion into science

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

A single drug, study failures leave Anavex with nothing but cash

focus

hotspot

focus

focus